Search

Never before has the industry moved so rapidly to find new treatments and vaccines – but safety and efficacy must remain top priorities.

Is it possible to design a bioreactor that can function in microgravity?

Sanofi and DNDi are co-developing a drug – acoziborole – to treat sleeping sickness.

Environmental sustainability should be a key consideration when selecting solvents for scale-up.

What lies beyond COVID-19? There are many diseases that could benefit from all the collaborative effort and funding being poured into COVID-19.

A $4-billion acquisition, a key finding for sarcopenia drug development, and algorithmic efficiency… What’s new in advanced medicine?

At JM, we’ve leveraged our knowledge and experience in scientific excellence to develop a novel process to synthesise ultra-pure cannabidiol (CBD)

What biosecurity risks do exo-microorganisms pose?

A look at the past, present, and future of vaccine production – and how COVID-19 changes the outlook.

A step closer to an off-the-shelf CAR T cell therapy.